Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-10-26
1981-07-14
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, G01N 3348, A61K 4300, G01T 100
Patent
active
042786525
ABSTRACT:
A process for the determination of ferritin in serum or in plasma is disclosed, which comprises incubating an antibody directed against an organ-specific isoferritin, which is covalently bound to nylon(polyamide 6,6), on the one hand with ferritin standard solutions and on the other hand with serum samples, decanting or aspirating the incubation solutions, washing the nylon-antibody-ferritin complex formed and subsequently incubating it with a iodine-labelled antibody directed against a second organ-specific isoferritin, isolating the nylon-antibody-ferritin-anti-body-.sup.125 I-complex formed, counting its radioactivity in the gamma counter and comparing the standard samples with the serum samples.
REFERENCES:
patent: 2955074 (1960-10-01), Hink
patent: 3372992 (1968-03-01), Storey et al.
patent: 3712291 (1973-01-01), Freeman
patent: 3925020 (1975-12-01), Ogawa et al.
Cowan Stuart I.
Niemann Elfriede
Stagg Brian H.
Hoechst Aktiengesellschaft
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Process for determining ferritin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for determining ferritin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for determining ferritin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2164596